IBM®
Skip to main content
    Country/region [change]    Terms of use
 
 
 
    Home    Products    Services & solutions    Support & downloads    My account    

IBM Journal of Research and Development

Systems Biology   Volume 50, Number 6, 2006
Table of contents: HTMLPDF This article: HTMLPDF   Copyright info

Model-based design approaches in drug discovery: A parallel to traditional engineering approaches - Author Bios

by B. Schoeberl,
U. B. Nielsen,
and R. Paxson
Biographical sketches of authors

Birgit Schoeberl Merrimack Pharmaceuticals, 101 Binney Street, Cambridge, Massachusetts 02142 (bschoeberl@merrimackpharma.com). Dr. Schoeberl is the director of Network Biology at Merrimack Pharmaceuticals. Together with Ulrik Nielsen, she helped formulate Merrimack's research and development platform, Network Biology. Dr. Schoeberl received an M.S. degree in chemical engineering from the University of Karlsruhe, Germany, and a Ph.D. degree from the Max-Planck-Institute for Dynamics of Complex Technical Systems, Magdeburg, Germany.

Ulrik B. Nielsen Merrimack Pharmaceuticals, 101 Binney Street, Cambridge, Massachusetts 02142 (unielsen@merrimackpharma.com). Dr. Nielsen is co-founder and vice president of research at Merrimack Pharmaceuticals. He directs all major functions and activities within the company's research and drug discovery programs. Dr. Nielsen received his Ph.D. degree in molecular biology from the University of Copenhagen, Denmark.

Ricardo Paxson The MathWorks Inc., 3 Apple Hill Drive, Natick, Massachusetts 01760 (pax@mathworks.com). Mr. Paxson is head of the Systems Biology group at The MathWorks Inc. He manages a team of engineers developing tools for modeling and simulation of biological systems. Mr. Paxson received B.S. and M.S. degrees in aeronautical engineering from the Massachusetts Institute of Technology.


    About IBMPrivacyContact